Why Fitness Matters More Than Ever: The Role of the Industry in GLP-1 Therapies
According to a recent EuropeActive report, the rapid spread of GLP-1 therapies is fundamentally reshaping the discussion on weight management and health across Europe. Originally developed for type 2 diabetes, these medications are increasingly used to treat obesity and are seen as a “game changer.” Yet one thing remains clear: medicine alone is not enough for sustainable health.
Why does this matter for the fitness industry?
GLP-1 users often experience rapid weight loss – but not only in fat mass. Muscle and bone mass can also decrease (up to 40% of lost mass according to studies). Without targeted exercise, long-term risks include loss of strength, reduced mobility, and higher injury risk. Research also shows that two-thirds of users discontinue therapy within a year, often leading to weight regain.
The role of fitness and exercise
This is where the fitness industry comes in: it provides spaces, programs, and expertise to close this gap. Resistance and strength training are essential to preserve muscle mass and maintain physical function. At the same time, exercise stabilizes the nervous system, supports mental health, and helps establish new routines.
New target groups – new opportunities
GLP-1 users are not a homogeneous group:
- People who have never trained regularly
- Returners after a long break
- Active individuals redefining their goals
This diversity requires tailored programs, including entry-level options and personalized support.
Conclusion
GLP-1 is not a “magic bullet” but a starting point. Sustainable results come only from combining medical therapy with an active lifestyle. The fitness industry has the chance to position itself as an essential partner for health and prevention.
